? ?Tazarotene (CAS 118292-40-3) - Product Overview? ?
Tazarotene is a third-generation topical retinoid widely used in dermatology for its potent efficacy in regulating skin cell proliferation and differentiation. It primarily treats ?psoriasis?, ?acne vulgaris?, and ?photoaging?, while also demonstrating anti-inflammatory and comedolytic properties. Suitable for pharmaceutical formulations, cosmetic products, and clinical research, Tazarotene is a versatile active ingredient trusted by healthcare professionals worldwide.

?? ?Key Benefits of Tazarotene? ??
? ?Rapid Action?: Clinically proven to reduce psoriatic plaques by 60-70% within 12 weeks[^1].
? ?High Efficacy?: 85% patient satisfaction in improving acne severity and skin texture[^2].
? ?Minimal Irritation?: Optimized formulations reduce redness and dryness compared to traditional retinoids.
? ?Dual Functionality?: Combats both acne and signs of aging, streamlining skincare routines.

?? ?Primary Applications? ??

• ?Prescription Medications?: Topical gels/creams for psoriasis and acne.

• ?Anti-Aging Skincare?: Serums and creams targeting wrinkles, hyperpigmentation, and sun damage.

• ?Dermatology Research?: Study of retinoid pathways and epidermal disorders.

• ?Cosmeceuticals?: OTC products for mild acne and skin renewal.

?? ?Quality & Compliance? ??

1. Purity: ≥99% (HPLC)

2. Standards: USP, EP, and ICH guidelines

3. Testing: Residual solvents, heavy metals, and stability per ISO 9001

4. Packaging: Sealed amber vials with nitrogen protection

?? ?Market Trends? ??
The global retinoid market is projected to grow at ?6.8% CAGR (2023-2030)?, driven by rising acne prevalence (affecting 9.4% of the global population) and demand for anti-aging solutions. Tazarotene gains traction due to its FDA-approved status for multiple indications and compatibility with combination therapies (e.g., with corticosteroids).